The activation of mTOR/4E‐BP1/c‐Myc signaling in QSOX2‐overexpressed ESCC cells was effectively inhibited by Ebselen treatment in vitro in a time‐ and concentration‐dependent manner (Figure S8A,B, Supporting Information). The gene discussed is MTOR; the disease is esophageal squamous cell carcinoma.